Earnings Labs
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ·Healthcare·Biotechnology

$4.73

-4.64%

Mkt Cap $7.91M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$7.00

Range $7.00$7.00

Implied Upside

+48.0%

Consensus $7.00 vs current $4.73